Analyst Ratings for Entrada Therapeutics (TRDA)
TRDA Rating Summary
TRDA Price Target Summary
- Highest: $21.00 (Oppenheimer)
- Lowest: $17.00 (Roth/MKM)
- Average: $19.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$19.33 (+53.7%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 88%
Avg. $ Target:
$19.33 (+53.7%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/10/2026 | Guggenheim | Debjit Chattopadhyay | New Coverage | Buy (N/A) |
20.00 (N/A) |
10.55 (12.58) |
19.24% | Details |
| 1/28/2026 | Oppenheimer | Hartaj Singh | New Coverage | Outperform (N/A) |
21.00 (N/A) |
11.00 (12.58) |
14.36% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
